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1098-612X/08/020167+08 $34.00/0Faecal samples were taken from cats living in multi-cat households with
endemic feline coronavirus (FCoV) infection. Total RNA was extracted from
faecal suspensions and FCoV RNA was quantified using a real-time reverse
transcriptase-polymerase chain reaction (RT-PCR) assay. The real-time RT-PCR
threshold cycle (CT) values were consistently high suggesting that the samples
contained very little viral RNA. However, experiments in which RNA extracted
from FCoV-infected cell culture supernatants was combined with RNA extracted
from faecal suspensions revealed the presence of faecal factors that significantly
inhibited the reverse transcription reaction. Consequently, three methods of
RNA extraction were investigated and RNA dilution was undertaken to
investigate whether the effects of the faecal inhibitors could be reduced. Our
results show that using the QIAgen RNA mini kit for RNA extraction and
dilution of the RNA samples helps to reduce the inhibitory effects. However,
because the extent of the inhibitory effects varied between faecal samples,
accurate quantification proved difficult. We, therefore, conclude that although
real-time RT-PCR provides an excellent method for detecting the presence of
viral shedding, quantification of FCoV RNA in faecal material has to take into
account the possible effects of RT-PCR inhibitors. It is, therefore, essential that all
new assays, and the methods of sample preparation, are carefully evaluated
before being used in a clinical setting.Date accepted: 17 October 2007  2007 ESFM and AAFP. Published by Elsevier Ltd. All rights reserved.F
eline coronavirus (FCoV) infection is ex-
tremely common in cats and in the United
Kingdom approximately 40% of the
domestic cat population have positive serum an-
tibody titres (Pedersen 1995). Where cats are
housed together in multi-cat households the
prevalence is even higher at around 90% (Addie
and Jarrett 1992, Sparkes et al 1992, Addie 2000).
Natural infections with FCoV are usually tran-
sient, although a significant percentage of infec-
tions may become persistent (Addie and Jarrett
2001). Most infections are asymptomatic or result
in mild, self-limiting gastrointestinal disease.
However, in a small percentage of animals, a fatal
multi-systemic, immune-mediated disease
known as feline infectious peritonitis (FIP) oc-
curs (Pedersen 1995). The devastating effects of-9558; Fax: þ44-117-928-
 2007 ESFM aFIP have made FCoV infection a significant con-
cern for veterinarians, cat owners and breeders
alike.
FCoVs are highly infectious. They are spread
predominantly by the faeco-oral route but also
in oro-nasal secretions and in urine (Hoskins
1993). Cats recovering from coronavirus infection
will shed virus in their faeces and are a potential
risk to other susceptible cats. Most cats will shed
virus for a period of a few weeks to months
either continuously or transiently (Addie and
Jarrett 2001, Lutz et al 2002b). Occasionally per-
sistent carriers are found which will shed virus
indefinitely (Addie and Jarrett 2001). In multi-
cat households a large proportion of cats
(75e100%) will be shedding coronavirus at any
given time (Pedersen 1995). Each individual cat
will undergo cycles of infection, shedding, recov-
ery and re-infection (Foley et al 1997a). Close
contact between infected and susceptible catsnd AAFP. Published by Elsevier Ltd. All rights reserved.
168 C Dye et alfacilitates the most effective transmission and is
important in the recirculation of virus allowing
maintenance of endemic infection. However, co-
ronavirus can persist in the environment for
3e7 weeks (Hoskins 1993) and the risk of trans-
mission via fomites also exists. There is no
known vertical transmission of the virus.
At the present time there are no effective treat-
ments available for cats with FIP and the disease
is invariably fatal. This means that, currently,
controls to prevent FCoV infection are the most
effective method for controlling FIP disease. A
number of control strategies have been used
based on either elimination or minimisation of
infection. Environmental controls are the most
widely used tool and good hygiene techniques
are essential. Coronaviruses are inactivated by
most household detergents (Maris 1990), but ap-
propriate cattery design is required to facilitate
effective disinfection and this is a major draw-
back in many ‘household breeding’ situations.
Keeping small group sizes (not more than five
cats housed together), reducing levels of inter-
current disease and minimising stress levels
will also reduce the incidence of FIP (Addie
and Jarrett 1992). Isolation and early weaning
protocols may also be beneficial to reduce the ex-
posure of young kittens that are at high risk of
infection. For multi-cat households with endemic
FCoV infection separation of cats within the
household according to their level of faecal shed-
ding has been advocated to help to accelerate the
rate of viral load reduction (Foley et al 1997a,
Addie and Jarrett 2001, Lutz et al 2002b). This
strategy requires frequent monitoring of FCoV
in faecal samples. Viral particles remain stable
in faeces for at least 10 days and faecal shedding
can be assessed using reverse transcriptase-
polymerase chain reaction (RT-PCR) assays to
detect the viral genome (Lutz et al 2002b). Re-
cently, quantitative real-time RT-PCR methods
have become available enabling the amount, as
well as the frequency, of virus shedding to be as-
sessed (Gut et al 1999). This could potentially be
a useful tool as high-level shedders pose a greater
threat of disease transmission (Foley et al 1997b).
Using this approach, a recent study showed that
the majority of cats (78%) were ‘low-level’ shed-
ders with shedding frequencies of less than 30%.
Approximately 20% of the cats were termed me-
dium-level shedders with shedding frequencies
of 30e90% and only 1% of the cats were high-
level shedders with shedding frequencies
exceeding 90% (Lutz et al 2002a). Taking four
faecal samples over a 3-week period has beensuggested to give a good indication of viral
load (Lutz et al 2002b).
The presence of faecal inhibitors that interfere
with the function of the reverse transcriptase and
DNA polymerase enzymes makes faecal RT-PCR
assays notoriously difficult (Chui et al 2004,
Radstrom et al 2004). The aim of this study
was, therefore, to investigate the significance
and occurrence of inhibitors that might interfere
with real-time RT-PCR assays for the detection of
FCoV RNA in faecal samples from domestic cats.Materials and methods
Maintenance of cell lines
Crandell Reese feline kidney cells (CrFK) were
a kind gift from Dr Allison German of the
University of Bristol. The cells were maintained
in Dulbecco’s modified Eagle’s media (DMEM)
with 10% (v/v) foetal bovine serum (FBS),
100 units/ml penicillin G sulphate, 100 mg/ml
streptomycin sulphate and 1 non-essential
amino acids. Cell monolayers were propagated
in 75 cm2 tissue culture flasks kept at 37C in
5% CO2 humidified incubators.
Preparation of virus stocks
Feline infectious peritonitis virus (FIPV), strain
79-1146 was purchased from the American
Type Culture Collection (VR-2202, ATCC). Virus
stocks were prepared by infecting subconfluent
(w80%) CrFK cell monolayers at a high multi-
plicity of infection. Cell monolayers were incu-
bated with virus diluted in media for 45 min at
37C in 5% CO2 humidified incubators. The cell
culture supernatant was then discarded and re-
placed with media. Cell culture supernatant con-
taining virus was harvested at 8 h after infection
and centrifuged at 800 g for 5 min. An aliquot
of the supernatant was taken for estimation of
the virus titre by 50% tissue culture infectivity
dose (TCID50) and the remainder was aliquoted
and stored at 80C.
Faecal samples
Faecal material was obtained from 19 healthy
cats living in multi-cat households with endemic
FCoV infection. The samples were taken by the
cat owners who removed fresh faecal pellets
from the litter trays, placed them in sterile pots
and posted them to the laboratory. Samples
were stored for a maximum of 72 h at 4C pend-
ing postage and 10% (w/v) faecal suspensions in
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mediately on receipt. The faecal suspensions
were stored at 80C.
RNA extraction using the QIAamp viral
RNA mini kit
RNAwas extracted from cell culture supernatant
and from 10% faecal suspensions using
a QIAamp viral RNA mini kit according to the
manufacturer’s instructions. Briefly, 140 ml ali-
quots of samples were lysed under highly dena-
turing conditions to inactivate RNAses.
Buffering conditions were then adjusted with
ethanol to provide optimal binding of RNA to
a silica-gel based capture membrane. Contami-
nants were washed away using two different
wash buffers. The RNA was eluted in 60 ml of
RNAse-free, low-salt buffer at room temperature
and was stored at 80C.
RNA extraction using QIAamp DNA stool mini kit
RNA was extracted from 200 ml of a 10% faecal
suspension in PBS using the QIAamp DNA stool
mini kit according to the manufacturer’s instruc-
tions. Briefly, the faecal samples were suspended
in buffer ASL (QIAgen, UK), which is designed
to remove inhibitory substances from stool sam-
ples. ‘InhibitEX’ was added to adsorb these
substances, which were then removed by
centrifugation. Following proteinase K treatment
the samples were bound to a silica-gel based
capture membrane, washed and then eluted in
a low-salt buffer. The eluted RNA was stored at
80C.
Boom method for RNA extraction from faeces
A 20 ml aliquot of extraction matrix (size fraction-
ated silica) was added to 1 ml of L6 buffer (8.3 M
guanidinium isothiocyanate, 83 mM TriseHCl
pH 6.4, 36 mM ethylene diamine tetra-acetic
acid (EDTA), 2% (v/v) Triton-X-100) containing
200 ml of a 10% faecal suspension. AfterTable 1. RT-PCR oligonucleotide primers and oligon
Oligonucleotide
name
Use N
P1b RT primer TCATAG
P009 Forward PCR primer AGCAAC
P010 Reverse PCR primer GGAAGG
P9/10P Taqman probe AATGGC
*Genbank accession number DQ010921.vortexing for 10 s the samples were incubated
for 15 min at room temperature. Following cen-
trifugation at 16,000 g for 15 s the RNA pellet
was washed twice with 1 ml of L2 buffer (8.3 M
guanidinium isothiocyanate, 83 mM TriseHCl
pH 6.4), twice with 1 ml of 70% ethanol and
once with 1 ml of acetone. The RNA was dried
at 56C for 5 min and was re-suspended in
50 ml of RNAse-free water containing 15 units
of human placental ribonuclease inhibitor
(HPRI). Following a 15-min incubation at 56C
the suspension was centrifuged at 16,000 g for
2 min and the RNA containing supernatant was
stored at 80C.Real-time RT-PCR assay design
Oligonucleotide primers for reverse transcription
(1b) and PCR (P009 and P010) and a Taqman
probe (P9/10P) were designed using the
‘Primer3’ software package (Table 1). The choice
of primers was based upon a consensus se-
quence derived from published sequence data
for five FCoV isolates obtained from the Gen-
bank database (A22378, AB086904, AB086903,
AB086902 and X56496). A 171 nucleotide region
spanning the membrane-nucleocapsid gene
junction was chosen for amplification because
these genes represent the most abundant
mRNA’s and nucleotide sequence in this region
of the genome is well conserved (Schreiber et al
1989, Jouvenne et al 1990, Tobler et al 1993).Real-time RT-PCR reaction
Superscript II RNAse H reverse transcriptase
was used to reverse transcribe viral RNA. RNA
samples containing 5 pmol of primer 1b were in-
cubated at 65C for 5 min and then chilled on ice.
The RNA-primer mix was then added to a 20 ml
reaction containing 15 units of human placental
ribonuclease inhibitor (HPRI), 1 mM dNTP,
0.01 M dithiothreitol (DTT) and 1 first strand
buffer (Invitrogen, UK). The reaction wasucleotide probe
ucleotide sequence Position in
FIPV 79-1146 genome*
CGGATCTTTAAACTTCTC 29012e29035
TACTGCCACRGGAT 26655e26674
TTCATCTCCCCAGT 26807e26826
CACACAGGGACAACGC 26781e26802
170 C Dye et alincubated at 42C for 2 min before the addition
of 200 units of Superscript II RT enzyme. The re-
action was incubated at 42C for 50 min followed
by 94C for 2 min. Samples were immediately
chilled on ice and stored at 20C. Real-time
PCR reactions were done in duplicate using Hot-
StarTaq mastermix according to the manufactur-
er’s instructions. A 25 ml reaction containing 2 ml
of cDNA template (10% of the RT reaction vol-
ume), 1 PCR mix (supplied by manufacturer),
0.25 mM primer P009, 0.25 mM primer P010 and
1.5 mM MgCl2 was made with 0.2 mM of the
50FAM/30BHQ-1 labelled P9/10P Taqman probe.
The reaction was incubated at 95C for 15 min.
The cDNA was then amplified using 45 cycles
of 95C for 10 s, 56C for 15 s and 72C for 15 s.Table 2. Real-time RT-PCR results for RNA sam-
ples extracted from the faeces of cats in multi-cat
households with endemic FCoV infection
Sample CT value
FIPV 79-1146 20.4
Faeces 1 37.2
Faeces 2 36.3
Faeces 3 38.4
Faeces 4 36.0
Faeces 5 39.0
Faeces 6 ()
Faeces 7 35.9
Faeces 8 37.4
Faeces 9 36.0
Faeces 10 36.5
Faeces 11 31.6
Faeces 12 33.2
Faeces 13 33.2
Water control ()
Results are expressed as threshold cycle (CT) values
and positive (FIPV 79-1146) and negative (water)
control samples are included. Negative results are
represented by ().Results
Real-time RT-PCR assay optimisation
Viral RNA from the supernatants of CrFK cells
infected with the laboratory stain FIPV 79-1146
was used as template for optimisation of the
real-time RT-PCR assay. Temperature gradients
revealed an optimum annealing temperature of
59C and 10-fold template dilution series re-
vealed good reaction efficiency (95.9%). Melt
curves (dF/dT vs temperature) done using an
SYBR green I reporter system were used to
confirm the absence of non-specific products
(data not shown). Subsequently, ‘quantification
graphs’ (fluorescence vs cycle number) were
used to compare threshold cycle (CT) values us-
ing a standard fluorescence threshold of
100 rfu. Confirmation of reaction efficiencies for
use of the assay with field strain virus was not
possible due to low CT values precluding the
use of serial dilutions. However, any reduction
in the RT-PCR reaction efficiency using field
strain RNA template would most likely result
from nucleotide discrepancies within the PCR
primer annealing sites. The P009, P010 and Taq-
man probe annealing sites on the RNA from sev-
eral of the clinical FCoV strains were sequenced
to check for primer mismatches. This revealed
good sequence conservation with a maximum
of two nucleotide mismatches per oligonucleo-
tide (data not shown). Further investigation re-
vealed that small reductions in RT-PCR reaction
efficiency resulting from these primer mis-
matches could be eliminated by reducing the
PCR annealing temperature from 59 to 56C.FCoV RNA in faecal samples
CrFK cells were infected with the laboratory
strain virus FIPV 79-1146 and RNAwas extracted
from the cell culture supernatant. Following re-
verse transcription the cDNA was diluted
1:1000 with AE buffer (QIAgen, UK) and 5 ml
was used as template in the real-time PCR assay.
Faecal material obtained from cats living in
multi-cat households was used to make a 1:10
faecal suspension in PBS and RNAwas extracted
using a QIAgen viral RNA mini kit. The faecal
RNA was reverse transcribed and the cDNA
was diluted to a 50 ml volume with AE buffer.
Five microlitres of the cDNA was used as tem-
plate in the real-time PCR assay. Negative (wa-
ter) controls were also included for both the RT
and PCR steps. The positive control FIPV 79-
1146 sample gave a low CT value as expected
and the negative controls failed to give any sig-
nal after 45 PCR cycles. All 13 faecal samples
tested had very high CT values (Table 2) suggest-
ing that the concentration of viral RNA in the
samples was extremely low. Significant degrada-
tion of the RNA was felt to be unlikely as FCoV
RNA has been shown to remain stable within
faecal samples for at least 10 days at room tem-
perature (Lutz et al 2002b) and processing
methods within the laboratory were specifically
chosen to minimise this problem. Further
Table 3. Real-time RT-PCR results for RNA isolated from faecal samples using different methods of RNA
extraction
FIPV
79-
1146
Faeces 14 Faeces 15 Faeces 16 Faeces 17 Media
control
RNA
water
control
PCR
water
control
Boom extraction method 36.4 34.9 40.5 34.1 36.2 () () ()
QIAgen viral RNA mini kit 20.2 35.0 34.5 31.8 32.8 () () ()
QIAgen stool DNA mini kit 21.1 38.1 37.4 33.3 34.0 () () ()
Results are expressed as threshold cycle (CT) values and positive (FIPV 79-1146) and negative (media and water)
controls are included. Negative results are represented as ().
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vestigate whether faecal inhibitors were a con-
founding factor.
Investigation of RNA extraction method
Three different methods of RNA extraction were
used to investigate whether the effects of faecal
inhibitors could be minimised during the RNA
extraction process. Two QIAgen methods, the
QIAamp viral RNA mini kit and the QIAamp
DNA stool mini kit were used according to the
manufacturer’s instructions. A third method de-
scribed by Boom et al (van der Hoek et al 1995)
was also used. Each of the three methods was
also used to extract RNA from FIPV 79-1146 in-
fected cell culture supernatant and from unin-
fected media as positive and negative controls,
respectively. For each sample the P009/P010
RT-PCR assay was run and water controls for
the RT and PCR steps were also included. The
QIAgen viral RNA mini kit achieved the lowest
CT values in the majority of the samples with
the QIAgen stool DNA mini kit giving CT values
ranging from one to three cycles higher (Table 3).
CT values obtained using the Boom extraction
method were inconsistent when compared to
the QIAgen methods. The FIPV 79-1146 sample
gave a CT value 16 cycles higher than that
achieved with the QIAgen viral RNA mini kit,Table 4. Comparison of threshold cycle (CT) values
culture supernatant ‘spiked’ with either faecal suspen
FIPV 79-1146 Faeces 19 M
CT value run 1 24.9 37.9 (
CT value run 2 24.9 37.7 (
Reactions were done in duplicate and the results of run 1
as ().yet in faecal sample 14 it gave almost the same
CT value as the QIAgen viral RNA mini kit. In
the remaining faecal samples the Boom method
gave CT values ranging from two to six cycles
higher than the Qiagen methods. Based on these
results the QIAgen viral RNA mini kit was cho-
sen as the method of faecal RNA extraction for
subsequent work.
Investigation of faecal inhibitors
RNA was extracted from 140 ml of FIPV 79-1146
infected cell culture supernatant, from a 1:10 fae-
cal suspension (faeces 19) and from uninfected
media. Also, 100 ml of an identical FIPV 79-1146
infected cell culture supernatant was ‘spiked’
with 40 ml of either uninfected media or with
the same faecal suspension and RNA was ex-
tracted using the same methods. Reverse tran-
scription was undertaken using primer 1b and
cDNA was amplified in the P009/P010 real-
time PCR reaction. A water control sample was
included and all samples were run in duplicate
(Table 4). The FIPV 79-1146 samples spiked
with faecal suspension gave CT valuesw9 cycles
higher than their media spiked equivalents. This
indicates that the presence of faecal material
prior to RNA extraction had decreased the ap-
parent viral content of the original sample by
a factor of w500 (29).from the RT-PCR of FIPV 79-1146 infected cell
sion or with uninfected media
edia FIPVþ faeces FIPVþmedia Water
) 38.8 28.4 ()
) 39.0 28.4 ()
and run 2 are shown. Negative results are represented
Table 6. Inhibition of the PCR reaction
FIPV cDNA
alone
FIPV
cDNAþ faecal
cDNA
Water
control
CT value for
run 1
17.8 18.2 ()
CT value for
run 2
18.1 18.4 ()
The results are expressed as threshold cycle (CT)
values and duplicate results are shown as run 1 and
run 2. Negative results are represented as ().
172 C Dye et alInhibition of the reverse transcription reaction
RNA was extracted from FIPV 79-1146 infected
cell culture supernatant and from a 1:10 faecal
suspension (faeces 19). Three 20 ml reverse tran-
scription reactions were done, each containing
10 ml of template as follows: tube 1: 3 ml FIPV
79-1146 RNAþ 7 ml water, tube 2: 3 ml FIPV
79-1146 RNAþ 7 ml faecal RNA, and tube 3:
3 ml waterþ 7 ml faecal RNA. The reactions
were diluted to a volume of 50 ml with AE buffer
(50 mM sodium acetate pH 5.3, 10 mM EDTA)
and 5 ml of each was used as template in a real-
time PCR reaction. Sample 1, containing viral
RNA alone, had a CT value w9 cycles lower
than that of sample 2, containing viral RNA
spiked with faecal suspension (Table 5). This in-
dicates that the presence of RNA extracted from
faecal suspension prior to reverse transcription
had reduced the apparent viral concentration in
the initial sample by a factor of w500 (29).
Inhibition of the PCR reaction
RNA was extracted from FIPV 79-1146 infected
cell culture supernatant and from a 1:10 faecal
suspension (faeces 19). Following reverse tran-
scription with primer 1b the cDNA was diluted
to a volume of 50 ml with AE buffer. Four PCR re-
actions were done each containing 5 ml of cDNA
template as follows: tube 1: 2.5 ml FIPVþ 2.5 ml
water, tube 2: 2.5 ml FIPV cDNAþ 2.5 ml faecal
cDNA, tube 3: 2.5 ml faecal cDNAþ 2.5 ml water,
and tube 4: 5 ml water. Tubes 1 and 2, containing
FIPV 79-1146 cDNA alone and FIPV 79-1146
cDNA spiked with faecal cDNA, respectively,
both had the same CT values (Table 6). This
shows that the presence of cDNA derived from
faecal suspension did not result in inhibition of
the PCR reaction.Table 5. Inhibition of reverse transcription by
faecal inhibitors
FIPV
RNA
alone
FIPV
RNAþ
faecal RNA
Faecal
RNA
alone
Water
control
CT value for
run 1
17.5 26.8 38.8 ()
CT value for
run 2
17.0 26.8 38.0 ()
The results are expressed as threshold cycle (CT)
values and duplicate results are shown as run 1 and
run 2. Negative results are represented as ().RNA dilution
RNA was extracted from FIPV 79-1146 infected
cell culture supernatant. Also, 100 ml of the
same FIPV 79-1146 infected cell culture superna-
tant was ‘spiked’ with 40 ml of faecal suspension
(faeces 19) and RNA was extracted using the
same method and solutions. Doubling dilutions
of the ‘spiked’ RNA were made in RNAse-free
water and 10 ml of each dilution was used as tem-
plate in the P009/P010 real-time RT-PCR reac-
tion. Positive (FIPV 79-1146 RNA) and negative
(water) controls were included and all reactions
were done in duplicate. The results are shown
in Table 7. Instead of the expected increase in
CT values with increasing viral RNA dilution,
the threshold cycle decreased with the first two
dilutions (1:2 and 1:4). This suggests that the di-
lution of faecal inhibitors was having a greater
effect than dilution of the viral RNA. At the 1:8
and 1:16 dilutions the CT values rose steadily
suggesting that further dilution was of no bene-
fit. A 7-cycle improvement in the CT value was
seen at the 1:4 dilution which equates to an in-
crease in the apparent initial virus concentration
by a factor of w130 (27). Subsequent testing
revealed that the optimal RNA dilution factor
was different for each individual faecal sample,
making a standardised protocol for accurate
quantification difficult to implement (data not
shown).Discussion
The results of our study show that the quantifica-
tion of FCoV RNA from faecal samples of
domestic cats using real-time RT-PCR is prob-
lematic because of the presence of enzyme inhib-
itors. A series of ‘spiking’ experiments showed
that this inhibition was a significant problem
Table 7. RNA template dilution
FIPV
79-1146
FIPVþ
faeces
FIPVþ
faeces
FIPVþ
faeces
FIPVþ
faeces
FIPVþ
faeces
Water
control
1:2 dilution 1:4 dilution 1:8 dilution 1:16 dilution
CT value run 1 21.1 36.7 35.0 29.1 30.0 30.5 ()
CT value run 2 21.1 36.8 35.5 29.1 29.6 30.5 ()
The results are expressed as threshold cycle (CT) values and duplicate results are shown as run 1 and run 2.
Negative results are represented as ().
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not for the PCR amplification step. This finding
could reflect the relative amounts of faecal-
derived material in the two reactions (50% of
the RT reaction volume are derived from faecal
RNA compared with only 2% of the PCR reac-
tion) or it may reflect the specific inhibition of
an enzyme activity. The effect of these inhibitors
was minimised by the use of the QIAgen viral
RNAmini kit for RNA extraction and by dilution
of RNA samples prior to reverse transcription. A
1:4 RNA dilution could be used empirically to
ensure that false negative RT-PCR results were
minimised. However, as our preliminary results
have shown that faecal samples contained vari-
able inhibitor concentrations, we believe that
quantitative assessment of faecal viral RNA con-
tent using this method may often be inaccurate.
Given the profound effects of faecal inhibitors
found in this study it may be that some cats des-
ignated as low level shedders using similar as-
says could actually be shedding virus at much
higher levels. Such results could have significant
clinical relevance if used as part of screening pro-
grammes within households attempting to re-
duce viral loads.
The results of this study are in broad agree-
ment with those of many other authors who
have experienced problems amplifying nucleic
acid from faecal material. For example, a recent
study evaluating eight methods for extracting
severe acute respiratory syndrome coronavirus
(SARS CoV) RNA from faecal material con-
cluded that the majority retained inhibitory sub-
stances preventing optimal amplification (Petrich
et al 2006). However, several previously pub-
lished studies quantifying FCoV faecal shedding
using real-time RT-PCR have not reported signif-
icant problems associated with faecal inhibitors.
It is possible that this problem has not been spe-
cifically addressed previously and that faecal
shedding of FCoV may, therefore, have been
commonly underestimated. However, it is also
possible that alternative protocols may succeedin satisfactorily overcoming the problem. For
example, in this study we only investigated the
use of one reverse transcriptase enzyme (Super-
script II RNAse H) and it is possible that other
RT enzymes may be less sensitive to the effects of
inhibitors. Nevertheless, our results suggest that
internal positive RT-PCR controls should be in-
cluded in future assays and that the potential
for variable levels of inhibitory factors in faecal
samples should be kept in mind. Performing
multiple assays using various RNA dilutions
may also be of benefit. The conclusion is, there-
fore, not that accurate quantification of FCoV
RNA in faeces is impossible but that each indi-
vidual assay should be carefully evaluated
before it is used in a clinical setting.References
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